Transcutaneous Administration of Imiquimod Promotes T and B Cell Differentiation into Effector Cells or Plasma Cells

We are interested in promoting the development of transcutaneous immunization using microneedle technology and attempting to apply an adjuvant with transcutaneous immunization to improve the efficacy and reduce the amount of antigen and number of administrations needed. In this study, we collected b...

Descripción completa

Detalles Bibliográficos
Autores principales: Hirobe, Sachiko, Yamasaki, Taki, Ito, Sayami, Quan, Ying-Shu, Kamiyama, Fumio, Tachibana, Masashi, Okada, Naoki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8878978/
https://www.ncbi.nlm.nih.gov/pubmed/35214117
http://dx.doi.org/10.3390/pharmaceutics14020385

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8878978/
https://www.ncbi.nlm.nih.gov/pubmed/35214117
http://dx.doi.org/10.3390/pharmaceutics14020385

Ejemplares similares